Detalhe da pesquisa
1.
Morgana acts as an oncosuppressor in chronic myeloid leukemia.
Blood
; 125(14): 2245-53, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25678499
2.
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase.
BMC Cancer
; 16: 314, 2016 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27184141
3.
Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex.
Int J Mol Sci
; 17(12)2016 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27916821
4.
HAUSP compartmentalization in chronic myeloid leukemia.
Eur J Haematol
; 94(4): 318-21, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082234
5.
Analysis of Escherichia coli isolated from patients affected by Crohn's disease.
Curr Microbiol
; 63(2): 131-7, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21626145
6.
IκB-α: At the crossroad between oncogenic and tumor-suppressive signals.
Oncol Lett
; 13(2): 531-534, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356925
7.
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.
Curr Drug Targets
; 18(4): 389-395, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27291926
8.
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.
Oncotarget
; 8(22): 35508-35522, 2017 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28418900
9.
The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia.
Oncol Lett
; 12(5): 3123-3126, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27899971
10.
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias.
Oncotarget
; 7(40): 66287-66298, 2016 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27563822
11.
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias.
Adv Hematol
; 2015: 612567, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26843864
12.
The Role of PTEN in Myeloid Malignancies.
Hematol Rep
; 7(4): 5844, 2015 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26734127
13.
BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation.
Cell Cycle
; 14(7): 973-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25608112
14.
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia.
Oncoscience
; 2(10): 880-91, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26682280
15.
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion.
Oncotarget
; 6(28): 25217-25, 2015 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26295305
16.
BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
PLoS One
; 9(10): e110682, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25343485
17.
Surveillance of methicillin-resistant Staphylococcus aureus isolated in Torino (northwest Italy).
Diagn Microbiol Infect Dis
; 69(3): 250-7, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21353947